Genmab is a leading international biotechnology company focused on
developing fully human antibody therapeutics for unmet medical needs. Using
cutting-edge antibody technology, Genmab's world class
discovery, development and manufacturing teams have created and
developed an extensive pipeline of products for potential treatment of a
variety of diseases including cancer and autoimmune disorders. As Genmab
advances towards a commercial future, we remain committed to our primary
goal of improving the lives of patients who are in urgent need of new
treatment options.
Learn more about Genmab
Genmab Events
Legal Notice
© 2008 Genmab A/S